N-{2-[(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide
N-{2-[(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide(221205-90-9)
- Name: N-{2-[(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide
- Synonyms:221205-90-9
- Molecular Formula:C16H19F2N3O6S
- Molecular Weight:419.4004
- CAS Registry Number:221205-90-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.221205-90-9 pyrimisulfan
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.221205-90-9 N-{2-[(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:N-{2-[(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.221205-90-9 Pyrimisulfan
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Application:for drug impurities, for drug standards,for drug research and development
Min. Order:0
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)]
Other Product
- 1331773-18-2/Pyridine, 2-hexyl-6-(3-thienyl)-
- 660847-06-3/HDAC inhibitor
- 918659-56-0/Chaetominine
- 1258861-20-9/LY2940680
- 1124329-14-1/9-Cyclopentyl-2-[[2-methoxy-4-[(1-methylpiperidin-4-yl)oxy]-phenyl]amino]-7-methyl-7,9-dihydro-8H-purin-8-one
- 209984-56-5/DIBENZAZEPINE
- 1234703-40-2/LY-2608204
- 1227923-29-6/3-[(1S,2S)-2-Hydroxycyclohexyl]-6-[(6-methyl-3-pyridinyl)methyl]benzo[h]quinazolin-4(3H)-one
- 1220510-45-1/N1-[(6S,10S)-6-Ethyl-2-[[[(4-fluorophenyl)methyl]amino]carbonyl]-6,7,9,10-tetrahydro-3-hydroxy-4-oxo-4H-pyrimido[1,2-d][1,4]oxazepin-10-yl]-N1,N2,N2-trimethylethanediamide
- 435345-47-4/Pyridinium, 3,5-bis(aminocarbonyl)-1-(phenylmethyl)-, bromide (1:1)
- 1315513-10-0/Phosphine oxide, (2,2-diethoxyethyl)bis(4-methylphenyl)-
- 552883-91-7/4-(3-FLUORO-4-NITROBENZYL)MORPHOLINE
- 505052-64-2/4-(5-BROMO-3-NITRO-PYRIDIN-2-YL)-MORPHOLINE
- 86261-44-1/Morpholine, 4-(1-ethyl-2-propynyl)- (9CI)
- 150047-50-0/(E)-OCTADEC-2-EN-13-YN-1-OL
- 187806-17-3/[(E)-5-Acetoxypent-3-enyl] acetate
- 892654-56-7/GGTI-DU40
- 765317-72-4/3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethyl-N-[4-[(2-thiazolylamino)sulfonyl]phenyl]-6-benzofuransulfonamide
- 221205-90-9/N-{2-[(4,6-dimethoxypyrimidin-2-yl)(hydroxy)methyl]-6-(methoxymethyl)phenyl}-1,1-difluoromethanesulfonamide
- 283159-90-0/valiphenal
- 394730-71-3/1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(difluoromethyl)sulfanyl]-5-[(pyridin-2-ylmethyl)amino]-1H-pyrazole-3-carbonitrile
- 447399-55-5/3-({[5-(difluoromethoxy)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazole
- 315208-17-4/1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(fluoromethyl)sulfanyl]-5-[(pyrazin-2-ylmethyl)amino]-1H-pyrazole-3-carbonitrile
- 140163-89-9/O-ethyl S-propyl [(2E)-2-(cyanoimino)-3-ethylimidazolidin-1-yl]phosphonothioate
- 26494-58-6/(6-CHLORO-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL)ACETIC ACID
- 886501-50-4/4-Chloro-3-(trifluoromethoxy)benzonitrile
- 912761-53-6/3-(4-AMINOMETHYL-PHENYL)-2-METHYL-PROPIONIC ACID ETHYL ESTER
- 902836-81-1/Morpholine, 2-methyl-2-(4-methylphenyl)-
- 585518-43-0/(2,4-DICHLORO-6-METHYL-PHENOXY)-ACETYL CHLORIDE
- 172478-05-6/1-ISOBUTYRYLPIPERIDIN-4-AMINE